Conditions and diseases
Atezolizumab for untreated PD-L1-positive locally advanced or metastatic urothelial cancer when cisplatin is unsuitable
Technology appraisal guidance [TA492]
06 December 2017
12 July 2018
Tools and resources
Information for the public
Review and download supporting evidence. Includes the full guideline if available.